EPHB6 and intestinal neoplasm: Here we demonstrate that, although EPHB6 germline mutations have been suggested to predispose to colorectal cancer32, the loss of EphB6 does not significantly contribute to intestinal tumor initiation, or the progression of tumors initiated either genetically (Apc mutations) or by carcinogen exposure (AOM) in animal models.